Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Melinda L. Telli, Lee S. Schwartzberg et al.|JAMA Oncology|2019Cited by 446